Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 19 studies | 49% ± 18% | |
| oligodendrocyte precursor cell | 14 studies | 52% ± 18% | |
| GABAergic neuron | 11 studies | 55% ± 27% | |
| oligodendrocyte | 11 studies | 32% ± 12% | |
| glutamatergic neuron | 10 studies | 55% ± 22% | |
| endothelial cell | 9 studies | 36% ± 12% | |
| neuron | 7 studies | 40% ± 18% | |
| interneuron | 5 studies | 61% ± 27% | |
| GABAergic interneuron | 3 studies | 63% ± 15% | |
| granule cell | 3 studies | 33% ± 18% | |
| ependymal cell | 3 studies | 67% ± 15% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 17 studies | 41% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 18937.17 | 2642 / 2642 | 100% | 154.23 | 703 / 705 |
| kidney | 94% | 3034.34 | 84 / 89 | 66% | 17.03 | 596 / 901 |
| thymus | 80% | 1704.45 | 522 / 653 | 72% | 17.32 | 435 / 605 |
| ovary | 77% | 2399.17 | 139 / 180 | 62% | 13.25 | 266 / 430 |
| skin | 27% | 1995.04 | 495 / 1809 | 95% | 71.28 | 448 / 472 |
| prostate | 44% | 752.59 | 108 / 245 | 72% | 11.69 | 363 / 502 |
| breast | 3% | 55.69 | 16 / 459 | 77% | 33.10 | 865 / 1118 |
| uterus | 32% | 655.87 | 54 / 170 | 31% | 7.72 | 144 / 459 |
| lung | 18% | 308.86 | 104 / 578 | 39% | 8.41 | 446 / 1155 |
| intestine | 41% | 777.42 | 397 / 966 | 14% | 2.48 | 73 / 527 |
| adrenal gland | 3% | 108.35 | 8 / 258 | 49% | 9.66 | 113 / 230 |
| bladder | 33% | 725.95 | 7 / 21 | 17% | 3.14 | 87 / 504 |
| blood vessel | 50% | 1416.72 | 661 / 1335 | 0% | 0 | 0 / 0 |
| esophagus | 23% | 382.87 | 339 / 1445 | 25% | 6.64 | 45 / 183 |
| muscle | 42% | 836.83 | 336 / 803 | 0% | 0 | 0 / 0 |
| pancreas | 4% | 84.23 | 14 / 328 | 34% | 6.24 | 61 / 178 |
| tonsil | 0% | 0 | 0 / 0 | 33% | 13.23 | 15 / 45 |
| eye | 0% | 0 | 0 / 0 | 33% | 4.57 | 26 / 80 |
| stomach | 9% | 145.61 | 34 / 359 | 15% | 2.70 | 42 / 286 |
| lymph node | 0% | 0 | 0 / 0 | 17% | 2.23 | 5 / 29 |
| liver | 0% | 0 | 0 / 226 | 13% | 2.88 | 53 / 406 |
| adipose | 8% | 144.66 | 101 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 7% | 114.41 | 18 / 241 | 0% | 0 | 0 / 0 |
| heart | 4% | 70.68 | 35 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0001701 | Biological process | in utero embryonic development |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0001666 | Biological process | response to hypoxia |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0007417 | Biological process | central nervous system development |
| GO_0007420 | Biological process | brain development |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0034751 | Cellular component | aryl hydrocarbon receptor complex |
| GO_0000785 | Cellular component | chromatin |
| GO_0005667 | Cellular component | transcription regulator complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0017162 | Molecular function | aryl hydrocarbon receptor binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
| GO_0003700 | Molecular function | DNA-binding transcription factor activity |
| GO_0046982 | Molecular function | protein heterodimerization activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ARNT2 |
| Protein name | ARNT2 protein Aryl-hydrocarbon receptor nuclear translocator 2 isoform D Aryl-hydrocarbon receptor nuclear translocator 2 isoform G Aryl-hydrocarbon receptor nuclear translocator 2 isoform B Aryl-hydrocarbon receptor nuclear translocator 2 isoform H Aryl-hydrocarbon receptor nuclear translocator 2 isoform C Aryl-hydrocarbon receptor nuclear translocator 2 isoform F Aryl hydrocarbon receptor nuclear translocator 2 (ARNT protein 2) (Class E basic helix-loop-helix protein 1) (bHLHe1) Aryl hydrocarbon receptor nuclear translocator 2 Aryl-hydrocarbon receptor nuclear translocator 2 isoform E |
| Synonyms | BHLHE1 KIAA0307 |
| Description | FUNCTION: Transcription factor that plays a role in the development of the hypothalamo-pituitary axis, postnatal brain growth, and visual and renal function . Specifically recognizes the xenobiotic response element (XRE). . |
| Accessions | ENST00000303329.9 [Q9HBZ2-1] X5D8U0 X5DP87 ENST00000527771.5 [Q9HBZ2-2] Q86TN1 X5DP31 H0YKW1 X5D7T2 Q9HBZ2 ENST00000533983.5 [Q9HBZ2-2] X5DRE4 ENST00000525103.1 X5DQN9 X5D9H9 X5DP40 |